MedTrace Logo

Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia

NCT06851910 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-04-29

No results posted yet for this study

Summary

This prospective observational study evaluates the effectiveness and safety of intravenous lacosamide as a rescue treatment for acute pain in patients presenting to the emergency department with trigeminal neuralgia

Conditions

  • Trigeminal Neuralgia

Interventions

DRUG

Lacosamide

Patients will be included if they are prescribed intravenous lacosamide for their trigeminal neuralgia exacerbation

Sponsors & Collaborators

  • Hospital Universitari de Bellvitge

    lead OTHER

Principal Investigators

  • Albert Muñoz Vendrell, PhD · Hospital Universitari de Bellvitge

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-21
Primary Completion
2026-12-31
Completion
2027-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06851910 on ClinicalTrials.gov